HS does not have to become severe. The trajectory of the disease is not fixed. Men who recognize the early signs, seek the right diagnosis, and take consistent action have significantly better outcomes than those who wait.
Early Warning Signs
Most men with HS describe their first symptoms as "just boils" or "ingrown hairs that got infected." The difference between a random boil and early HS is recurrence and pattern.

Red Flags That Suggest HS (Not Just a Boil)
- A painful lump in the armpit, groin, buttocks, or perianal area that keeps coming back in the same spot
- Multiple lesions appearing in the same general area at the same time
- A lesion that drains and heals, then returns within weeks
- A lump that you can feel a cord or tunnel under the skin near
- Scarring or thickened skin in areas where you have had repeated boils
- A family member with similar recurrent boils or 'cysts'
If two or more of these apply to you, ask your doctor specifically about hidradenitis suppurativa. Do not wait for the lesions to become severe before seeking evaluation.
What to Do Early
Early action does not require a formal diagnosis. You can start reducing triggers and improving skin health before you have seen a specialist.

1. Get the right diagnosis
Do this firstSee a dermatologist, not just a GP or urgent care. Ask specifically: 'Could this be hidradenitis suppurativa?' Bring photos of past lesions if you have them.
2. Address weight if relevant
High impactObesity is the strongest modifiable risk factor for HS severity. Even a 10-15% reduction in body weight has been shown to reduce flare frequency. This is not about appearance, it is about inflammation load.
3. Stop smoking
High impactSmoking is a major HS trigger. Nicotine stimulates follicular plugging and inflammation. Smoking cessation is one of the most evidence-backed lifestyle interventions for HS.
4. Reduce friction
Easy winSwitch to loose-fitting, moisture-wicking underwear and clothing. Avoid tight jeans, synthetic fabrics, and anything that creates sustained friction in affected areas.
5. Change your cleansing routine
Easy winUse a gentle, fragrance-free antiseptic wash (Hibiclens or benzoyl peroxide wash) in affected areas. Avoid scrubbing, which worsens inflammation.
6. Track your flares
Builds over timeKeep a simple log of when flares occur, where they appear, and what preceded them. This helps identify personal triggers and gives your doctor useful information.
Medical Options at Early Stages
Early-stage HS (Hurley I) has more treatment options and better outcomes than advanced disease. Do not assume you need to wait until things get worse before seeing a doctor.
Topical treatments
- Clindamycin 1% solution or gel
- Benzoyl peroxide wash
- Resorcinol cream for active lesions
Oral antibiotics
- Doxycycline (first-line)
- Clindamycin + rifampicin (combination)
- Tetracycline for milder cases
Procedures
- Intralesional corticosteroid injection for acute flares
- Deroofing of shallow sinus tracts
- Laser hair removal to reduce follicular triggers
Biologics (early consideration)
- Adalimumab (Humira) approved for moderate-severe HS
- Secukinumab (Cosentyx) approved for adults
- Consider early if disease is progressing despite antibiotics
The Case for Acting Early
Once HS progresses to sinus tracts and scarring (Hurley Stage II-III), the damage to skin and tissue is largely irreversible. Surgery can remove affected tissue, but it cannot undo years of scarring. The window for preventing that damage is early in the disease course.
Related Resources
Frequently Asked Questions
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment of hidradenitis suppurativa.
References
- [1] Jemec GB. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158-164.
- [2] Alikhan A, et al. North American clinical management guidelines for hidradenitis suppurativa. J Am Acad Dermatol. 2019;81(1):76-90.
- [3] Garg A, et al. Prevalence and co-morbidities of hidradenitis suppurativa in the United States. Dermatology. 2014;228(3):261-265.
- [4] Zouboulis CC, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619-644.
- [5] Kimball AB, et al. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157(12):846-855.